Clinical trial
Real World Pharmacokinetics of Immune Checkpoint Inhibitors
NCT04833075 · Radboud University Medical Center, Other · Terminated
Key facts
| NCT number | NCT04833075 |
|---|---|
| Title | Real World Pharmacokinetics of Immune Checkpoint Inhibitors |
| Official title | Real World Pharmacokinetics of Immune Checkpoint Inhibitors |
| Acronym | ELICIT |
| Lead sponsor | Radboud University Medical Center, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Other |
| Interventions | blood sampling |
| Enrollment | 19 |
| Start date | Sep 15, 2021 |
| Primary completion | May 15, 2023 |
| Completion | May 15, 2023 |
| First posted | Apr 6, 2021 |
| Last update posted | May 31, 2023 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: